Post Marketing Surveillance Study for ONIVYDE in South Korea.
Phase of Trial: Phase IV
Latest Information Update: 24 May 2019
Price : $35 *
At a glance
- Drugs Irinotecan (Primary) ; Fluorouracil; Folinic acid
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Adverse reactions
- Sponsors Shire; Takeda
- 31 Aug 2018 Biomarkers information updated
- 14 Mar 2018 Status changed from not yet recruiting to recruiting.
- 28 Feb 2018 New trial record